FDA approves first artificial iris
The U.S. Food and Drug Administration approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part...
Read MoreThe U.S. Food and Drug Administration approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part...
Read MoreIn a flourishing industry, the manufacturing and distribution of fake and counterfeit products is inevitable. The global circulation of fake and counterfeit products is prevalent and causes a great deal...
Read MoreSkinCeuticals Retinol 0.5 and Retinol 1.0 are now available with new improved formulations to ensure maximum efficacy and stability to enhance skin appearance and promote good skin health. SkinCeuticals Retinol...
Read More“Achieving Aesthetic Excellence” Conference takes place on 30TH June 2018,bringing key speakers including Dr Suzan Obagi, Obagi Medical, Dr Eccleston, MediZen and Marcus Haycock, Allergan Dr Suzan Obagi is to visit...
Read MoreAlfred MARCHAL joins ALPHASCIENCE as Chief Research Officer to take over all Alphascience research and development projects. He will run and develop the new Alphascience R&D center to work on fundamental...
Read MoreSingapore-based biotech company CellResearch Corporation is proud to announce two educational presentations on their breakthrough stem-cell based cosmeceutical range taking place at the FACE Conference, London (14-16th June...
Read MoreTheradome Inc., a Silicon Valley based medical device company, received FDA clearance to market its proprietary LH80 PRO hair restoration device to men. Around 50% of men will experience noticeable hair loss by the...
Read MoreDermapenWorld is proud to announce that the Revolutionary Dermapen 4 won the “GOOD DESIGN AWARD” in the medical and scientific category at the 60th anniversary of GOOD DESIGN AUSTRALIA held...
Read More